241 related articles for article (PubMed ID: 17307250)
21. RNA interference--a silent but an efficient therapeutic tool.
Ramachandran PV; Ignacimuthu S
Appl Biochem Biotechnol; 2013 Mar; 169(6):1774-89. PubMed ID: 23340870
[TBL] [Abstract][Full Text] [Related]
22. RNA interference for studying the molecular basis of neuropsychiatric disorders.
Hoyer D
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):122-9. PubMed ID: 17436547
[TBL] [Abstract][Full Text] [Related]
23. Focusing on RISC assembly in mammalian cells.
Hong J; Wei N; Chalk A; Wang J; Song Y; Yi F; Qiao RP; Sonnhammer EL; Wahlestedt C; Liang Z; Du Q
Biochem Biophys Res Commun; 2008 Apr; 368(3):703-8. PubMed ID: 18252196
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic application of RNA interference for hepatitis C virus.
Watanabe T; Umehara T; Kohara M
Adv Drug Deliv Rev; 2007 Oct; 59(12):1263-76. PubMed ID: 17822803
[TBL] [Abstract][Full Text] [Related]
25. RNA interference in cancer.
Gartel AL; Kandel ES
Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
[TBL] [Abstract][Full Text] [Related]
26. p53 gene therapy using RNA interference.
Berindan-Neagoe I; Balacescu O; Burz C; Braicu C; Balacescu L; Tudoran O; Cristea V; Irimie A
J BUON; 2009 Sep; 14 Suppl 1():S51-9. PubMed ID: 19785070
[TBL] [Abstract][Full Text] [Related]
27. Exploring in vitro roles of siRNA in cardiovascular disease.
Tang Y; Ge YZ; Yin JQ
Acta Pharmacol Sin; 2007 Jan; 28(1):1-9. PubMed ID: 17184576
[TBL] [Abstract][Full Text] [Related]
28. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
[TBL] [Abstract][Full Text] [Related]
29. [Vector systems of RNA interference].
Kazachenko KIu; Avdonin PV
Ontogenez; 2006; 37(3):163-70. PubMed ID: 16813217
[TBL] [Abstract][Full Text] [Related]
30. [RNA interference for cancer therapies].
Ashihara E
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2033-41. PubMed ID: 21084799
[TBL] [Abstract][Full Text] [Related]
31. siRNAs: their potential as therapeutic agents--Part I. Designing of siRNAs.
Hajeri PB; Singh SK
Drug Discov Today; 2009 Sep; 14(17-18):851-8. PubMed ID: 19540928
[TBL] [Abstract][Full Text] [Related]
32. Harnessing RNA interference for the treatment of viral infections.
Arbuthnot P
Drug News Perspect; 2010; 23(6):341-50. PubMed ID: 20697601
[TBL] [Abstract][Full Text] [Related]
33. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
34. The factors that contribute to the long-term expression of siRNA.
Shiota M; Ikeda Y; Wadhwa R
Nucleic Acids Symp Ser (Oxf); 2006; (50):243-4. PubMed ID: 17150908
[TBL] [Abstract][Full Text] [Related]
35. Potential role of RNAi in the treatment of HCV infection.
Volarevic M; Smolic R; Wu CH; Wu GY
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):823-31. PubMed ID: 17914916
[TBL] [Abstract][Full Text] [Related]
36. Transkingdom RNA interference (tkRNAi): a novel method to induce therapeutic gene silencing.
Nguyen TA; Fruehauf JH
Methods Mol Biol; 2009; 514():27-34. PubMed ID: 19048211
[TBL] [Abstract][Full Text] [Related]
37. RNA interference technologies and their use in cancer research.
Gaither A; Iourgenko V
Curr Opin Oncol; 2007 Jan; 19(1):50-4. PubMed ID: 17133112
[TBL] [Abstract][Full Text] [Related]
38. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
39. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
Mook OR; Baas F; de Wissel MB; Fluiter K
Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
[TBL] [Abstract][Full Text] [Related]
40. RNA interference for the treatment of cancer.
Putral LN; Gu W; McMillan NA
Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
